LONDON (Reuters) - The London 2012 Olympic anti-doping laboratory will be developed after the Games into what officials say will be a world-class research facility that could help revolutionise healthcare.
The lab, which was provided and kitted out by British drugmaker GlaxoSmithKline (GSK) to carry out more than 6,000 drug tests during the London Olympic and Paralympic Games, is to become a so-called Phenome Centre for scientists seeking to develop better and more targeted medical treatments.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!